Cytokinetics CYTK Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's total current liabilities?
- Cytokinetics (CYTK) reported total current liabilities of $199.19M in Q1 2026.
- How has Cytokinetics's total current liabilities changed year-over-year?
- Cytokinetics's total current liabilities increased by 24.7% year-over-year, from $159.73M to $199.19M.
- What is the long-term trend for Cytokinetics's total current liabilities?
- Over 5 years (2020 to 2025), Cytokinetics's total current liabilities has grown at a 45.4% compound annual growth rate (CAGR), from $31.2M to $202.45M.
- What does total current liabilities mean?
- The total amount of debt and obligations due within one year.
- How do you interpret total current liabilities?
- A high ratio relative to current assets may indicate liquidity stress, while a low ratio suggests strong short-term financial health.
- How does total current liabilities compare across companies?
- Must be compared against current assets to determine the current ratio.